α2-macroglobulin receptor as a receptor for CTGF
AssigneeFibroGen, Inc.
InventorsPatricia R. Segarini, James E. Nesbitt, David F. Carmichael
Life of this patent
Estimating the term…
Abstract
The invention provides a connective tissue growth factor (CTGF) receptor and biochemical and/or biological equivalents, homologs, derivatives, subunits, fragments, and complexes thereof. The CTGF receptor is useful in the treatment and diagnosis of CTGF-associated disorders and in methods of screening for agents that effect CTGF receptor expression and activity. The invention further provides nucleic acid sequences encoding the CTGF receptor, recombinant DNA molecules comprising these sequences, and transformed hosts carrying the recombinant DNA molecules, antisense sequences and antibodies directed against CTGF receptor, and pharmaceutical compositions for use in treatment of CTGF-associated disorders.
Claims7
A method for identifying an agent that modulates the activity of a CTGF receptor wherein the CTGF receptor is the α2-macroglobulin receptor, the method comprising:
- (a) combining a candidate agent with CTGF polypeptide and the CTGF receptor;
- (b) detecting the level of CTGF receptor activity in the sample;
- and
- (c) comparing the level of CTGF receptor activity in the sample to a standard level of CTGF receptor activity.
Dependencies are inferred from the claim text.